You are in the right place if you are looking for TMS Therapy for Depression in West Palm Beach. TMS therapy generates a lot of questions from people encountering it for the first time — and the questions are understandable. Magnetic pulses. Brain stimulation. A treatment that doesn’t involve medication. For anyone who’s spent years managing depression through prescriptions and appointments, TMS can sound either promising or intimidating before you understand what it actually involves.
This guide is designed to answer those questions directly: what TMS is, how it works biologically, what a course of treatment looks like in practice, who it’s designed for, and what the evidence says. By the end, you’ll have enough information to decide whether this is a conversation worth having with a specialist.
What TMS Actually Is
Transcranial Magnetic Stimulation (TMS) is a non-invasive procedure that uses magnetic fields to stimulate specific areas of the brain. “Non-invasive” here means exactly what it sounds like: nothing is inserted, no surgery is performed, no anesthesia is required, and the procedure doesn’t affect the rest of the body the way a medication does. The magnetic pulses are delivered through a coil placed against the scalp, targeting neural tissue directly beneath without any systemic involvement.
The specific target in depression treatment is the dorsolateral prefrontal cortex (DLPFC) — a region of the brain that regulates mood, emotional processing, and cognitive flexibility, and that research has consistently shown to be underactive in people with major depressive disorder. By delivering repeated magnetic pulses to this area, TMS works to increase its activity and normalize patterns of connectivity with other regions involved in mood regulation. The underlying mechanism is neuroplastic: TMS doesn’t simply provide temporary stimulation. Over a course of treatment, it prompts the brain to reorganize neural activity in ways that can persist beyond the treatment period. (1)
The Evidence Base
TMS received initial FDA clearance for the treatment of major depressive disorder in 2008, making it one of the longer-established non-medication treatments in psychiatry. That clearance was based on randomized, controlled clinical trial data demonstrating its effectiveness for patients who hadn’t responded to antidepressant medication. In the years since, TMS has received additional FDA clearances for OCD and, in 2025, for an accelerated treatment protocol for depression.
A 2022 clinical study published in the Turkish Journal of Medical Sciences examined TMS specifically in patients with treatment-resistant depression, using a double-blind, crossover design. Among 38 patients who received active TMS, 63 percent responded to treatment and 42 percent reached remission — outcomes that are particularly meaningful given that this population had already failed to respond to medication. (1) A broader review of TMS literature by researchers at Emory University and Brown University, published in Neuropsychopharmacology in 2023, confirmed that accelerated TMS protocols show similar efficacy to standard protocols while significantly compressing the treatment timeline. (2)
The Cleveland Clinic, in its patient-facing clinical guidance, describes TMS as a safe, non-invasive therapy used when other treatments haven’t worked, noting that it doesn’t require surgery or sedation and typically produces mild or no side effects. (3) That characterization aligns with what a significant body of clinical literature shows: TMS is well-tolerated, with a safety profile that compares favorably to both antidepressant medications and more intensive procedures like ECT.
What Happens During a TMS Session
Walking into a TMS appointment for the first time, the setup is simpler than most patients expect. You sit in a chair — no hospital gown, no IV, no sedation. A technician positions the magnetic coil against your scalp at a specific location calibrated to your individual anatomy. The coil then delivers a series of magnetic pulses in a controlled sequence. Some people feel a tapping or light clicking sensation at the treatment site. Others describe a mild tapping sensation on the scalp. The session runs, and when it’s done, you get up and go about your day.
Sessions typically run under 30 minutes. For many patients, a standard course involves sessions five days a week over four to six weeks. Accelerated protocols, in which multiple sessions are delivered per day over a shorter total period, have been developed for patients who need faster results or have scheduling constraints — with emerging evidence showing comparable outcomes to traditional schedules. (2)
There is no recovery time. Patients drive themselves to and from appointments, return to work, pick up children from school, and carry on with their normal routine immediately. This is not an insignificant practical advantage for people who have lives that don’t easily accommodate intensive treatment.
Side Effects and Safety
The side effects associated with TMS are notably mild compared to most medical treatments for depression. The most commonly reported are scalp discomfort at the treatment site and transient headache during or shortly after sessions, both of which are generally described as manageable and typically diminish as treatment progresses. (3) Unlike antidepressant medications, TMS produces no weight gain, no sexual dysfunction, no sleep disruption, no gastrointestinal effects, and no cognitive side effects.
Seizures are the most serious potential risk associated with TMS and are extremely rare — occurring at a rate substantially lower than those associated with antidepressant medications themselves. Standard safety screening before beginning treatment identifies and excludes patients for whom TMS would carry elevated risk, including those with metal implants in or near the head or a personal history of seizure disorder.
TMS is not appropriate for everyone. The evaluation process before beginning treatment exists precisely to confirm candidacy, ensure safety, and personalize the approach.
Who TMS Is Designed For
TMS is specifically designed for adults with major depressive disorder who have not achieved adequate relief from antidepressant medication. It is an appropriate option for patients who have tried one or more antidepressants without sufficient benefit, for those who cannot tolerate the side effects of medication-based treatment, and for those who prefer a non-pharmacological approach.
It has also demonstrated clinical utility in treating OCD, and ongoing research is exploring its application in anxiety, PTSD, and other conditions. A 2025 consensus review noted that TMS is now FDA-cleared for adolescents aged 15 and older with MDD, expanding access to a population that historically had fewer treatment options. (4)
What TMS is not, and is not designed to be, is a rescue treatment for acute psychiatric emergencies. Patients in acute crisis requiring immediate symptom relief are more likely to be directed initially toward rapid-acting options like IV ketamine or SPRAVATO® before beginning a TMS course. The two approaches are not mutually exclusive, and combining them as part of a broader treatment plan is an option that a clinical evaluation can address.
TMS at Hope Therapeutics in West Palm Beach
For patients in the Palm Beach area, TMS is available at Hope Therapeutics on Flagler Drive — a clinic specifically structured around interventional psychiatry rather than general psychiatric practice. The clinical team includes expertise in both standard and accelerated TMS protocols, in the evaluation of treatment-resistant presentations, and in the coordination of TMS with other neuroplastic treatments when a combined approach is indicated.
TMS is also designed to work alongside care you’re already receiving. Patients commonly continue with their existing therapist or maintain current medication management while completing a TMS course — the two don’t conflict, and research suggests the combination may support better outcomes than either approach alone. The first step is a consultation: a clinical conversation about your treatment history, your current situation, and whether TMS fits your profile. If it does, the team builds a plan from there. If a different treatment — or a combination — is better suited, the evaluation will surface that as well.
Take the Next Step
If you’re in the West Palm Beach area and you’re exploring TMS as an option for treatment-resistant depression, Hope Therapeutics in West Palm Beach offers a comprehensive consultation to assess whether TMS, IV Ketamine, SPRAVATO®, Ketamine-Assisted Psychotherapy, or Medication Management may be appropriate for your situation.
Hope Therapeutics 1515 N Flagler Dr, Suite 800 | West Palm Beach, FL 33401 📞 561-372-8705 Schedule a Consultation
References
- Akpinar K, Kalkan Oğuzhanoğlu N, Toker Uğurlu T. Efficacy of transcranial magnetic stimulation in treatment-resistant depression. Turkish Journal of Medical Sciences. 2022. DOI: 10.55730/1300-0144.5441. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387872/
- van Rooij SJH, Arulpragasam AR, McDonald WM, Philip NS. Accelerated TMS — moving quickly into the future of depression treatment. Neuropsychopharmacology. 2023. DOI: 10.1038/s41386-023-01599-z. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10700378/
- Cleveland Clinic. Transcranial magnetic stimulation (TMS): what it is. Cleveland Clinic. Available at: https://my.clevelandclinic.org/health/treatments/17827-transcranial-magnetic-stimulation-tms
- UTHealth Houston Department of Psychiatry and Behavioral Sciences. A new consensus on transcranial magnetic stimulation (TMS). April 2025. Available at: https://med.uth.edu/psychiatry/2025/04/21/a-new-consensus-on-transcranial-magnetic-stimulation-tms/
The information in this article is intended for educational purposes only and does not constitute medical advice. The treatments described may not be appropriate for every individual. Please consult a qualified healthcare provider to discuss your specific situation, medical history, and treatment options before making any decisions about your care.
